Founded November 2013
Stage Business development
Investors The Trendlines Group, private investor
CEO Joseph Flomenblit, PhD
S.T. Stent is developing a removable stent for insertion after Functional Endoscopic Sinus Surgery (FESS) to keep the sinus cavity open for up to 28 days, long enough for the tissue to heal.
The stent improves patient outcomes and reduces the probability of revision surgeries.
One issued patent (United States), two pending (Canada, Europe, Japan, China)
ST Stent CEO Joseph Flomenblit presents at a Trendlines Showcase.
More than 25 years’ experience developing stents; international expert in nitinol alloy; scientific advisor for Boston Scientific, J&J, Stryker, Velocimed, Rafael; founder, Litana; inventor, more than 60 patents; PhD, physics
International expert in inventive problem-solving theory (TRIZ); 15 years’ experience in medical device industry; former head of mechanical design, Medinol; consults to medical device start-ups; MSc, engineering
Medical research experience at Sheba Medical Center; regulatory experience at Mediwound; MSc, biology
Trendlines’ board of directors since 2007; co-founder, CEO, and director, Bio-Cell; director, D.N.A. Biomedical Solutions Industries; chairman, Protalix
Chairman, Otolaryngology-Head and Neck Surgery, Lenox Hill Hospital, New York
Head of Nose and Sinus Institute, Rabin Medical Center, Israel; leading surgeon in the ENT field
Chronic sinusitis is constant inflammation of the sinus caused by infection or allergy and characterized by facial pain and pressure, nasal congestion, and headaches. When drug treatments fail, Functional Endoscopic Sinus Surgery (FESS) is performed to improve airflow within the nose and sinuses, improve drainage, and eliminate diseased tissue.
Unfortunately, up to 30% of sinus surgeries fail due to scarring and recurrent inflammation that closes the nasal openings and requires revision sinus surgery (RSNA RadioGraphics). According to Intersect ENT, the estimated sinus stent market opportunity exceeds $3 billion in the United States
There are more than 1 million FESS procedures performed annually in the United States and Europe.